Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076544 · ClinicalTrials.gov registry record · Phase 3
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
A Phase 3 study, sponsored by Elan Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT00076544 is a Phase 3 study that has completed, run by Elan Pharmaceuticals. The registered enrollment target is 300 participants.
The verdict
NCT00076544, a Phase 3 study, has completed, sponsored by Elan Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide.
Interventions
- DRUG Ziconotide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2004-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00076544
The ClinicalTrials.gov registry entry for NCT00076544 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elan Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ziconotide is the first listed.
NCT00076544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00076544 about?
NCT00076544 is a clinical study titled "Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain". The purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide.
What is the current status of trial NCT00076544?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2004-02.
What interventions are being tested in trial NCT00076544?
The interventions under investigation include: Ziconotide (DRUG).
Who is sponsoring clinical trial NCT00076544?
This trial is sponsored by Elan Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.